Is it Beneficial to Add Pharmacotherapy to Cognitive-Behavioral Therapy when Treating Anxiety Disorders? A Meta-Analytic Review.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  International Journal of Cognitive Therapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1521/IJCT.2009.2.2.160PMID 19714228PMCID PMC2732196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cognitive enhancers for anxiety disorders.

  2011cited by this paper
• Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study

  2011cited by this paper
• Novel approaches to treatment of generalized anxiety disorder

  2010cited by this paper
• Treatment of panic.

  2010cited by this paper
• DISORDERS : A META-ANALYSIS OF RANDOMIZED PLACEBO-CONTROLLED TRIALS

  2008cited by this paper
• Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials.

  2008cited by this paper
• Enhancing exposure-based therapy from a translational research perspective.

  2007cited by this paper
• Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders

  2007cited by this paper
• Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up.

  2006cited by this paper
• Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine.

  2006cited by this paper
• Psychotherapy plus antidepressant for panic disorder with or without agoraphobia

  2006cited by this paper
• A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder

  2005cited by this paper
• Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

  2005cited by this paper
• Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

  2004cited by this paper
• The treatment of social anxiety disorder.

  2004cited by this paper
• Pharmacotherapy of anxious disorders

  2002cited by this paper
• Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo.

  2002cited by this paper
• Absence of Neuropsychologic Deficits in Patients Receiving Long-Term Treatment With Alprazolam-XR for Panic Disorder

  2001cited by this paper
• Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

  2000cited by this paper
• Fixed- and random-effects models in meta-analysis.

  1998cited by this paper
• Cognitive behavioural therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety?

  1998cited by this paper
• Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo

  1998cited by this paper
• Multicenter collaborative panic disorder severity scale.

  1997influential reference
• The Brief Social Phobia Scale: a psychometric evaluation

  1997cited by this paper
• Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review.

  1997cited by this paper
• Assessing the quality of reports of randomized clinical trials: is blinding necessary?

  1996cited by this paper
• Fluvoxamine, placebo, and cognitive behaviour therapy used alone and in combination in the treatment of panic disorder and agoraphobia

  1996cited by this paper
• Alprazolam and Exposure Alone and Combined in Panic Disorder with Agoraphobia

  1993cited by this paper
• Meta-analytic procedures for social research

  1993influential reference
• The assessment and treatment of performance anxiety in musicians.

  1991cited by this paper
• Behaviour Therapy and Benzodiazepines: Allies or Antagonists?

  1990cited by this paper
• A controlled comparison of cognitive- behaviour therapy, Diazepam, and placebo, alone and in combination, for the treatment of generalised anxiety disorder

  1990cited by this paper
• A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder.

  1990cited by this paper
• The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

  1989cited by this paper
• The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability

  1989cited by this paper
• Statistical Power Analysis for the Behavioral Sciences (2nd ed.)

  1989cited by this paper
• An empirically derived inventory to measure social fears and anxiety: The Social Phobia and Anxiety Inventory.

  1989cited by this paper
• Comment: Assumptions and Procedures in the File Drawer Problem

  1988cited by this paper
• Validity and factorial structure study of the compulsive activity checklist

  1988cited by this paper
• An inventory for measuring clinical anxiety: psychometric properties.

  1988cited by this paper
• Statistical Methods for Meta-Analysis

  1987cited by this paper
• Social phobia.

  1987cited by this paper
• The Hospital Anxiety and Depression Scale.

  1987cited by this paper
• Stage fright in orchestral musicians: a study of cognitive and behavioural strategies in performance anxiety.

  1987cited by this paper
• Anxiety sensitivity, anxiety frequency and the prediction of fearfulness.

  1986cited by this paper
• Comparative analysis of two rates.

  1985cited by this paper
• Meta-analytic procedures for social research

  1984cited by this paper
• The Hospital Anxiety and Depression Scale

  1983cited by this paper
• Behavioural psychotherapy.

  1983cited by this paper
• The Clinical Anxiety Scale: An Instrument Derived from the Hamilton Anxiety Scale

  1982cited by this paper
• Brief standard self-rating for phobic patients.

  1979cited by this paper
• Nursing in behavioural psychotherapy : an advanced clinical role for nurses

  1977cited by this paper
• Modifying Solo Performance Anxiety in Adult Pianists

  1976cited by this paper
• A self-rating scale of distress

  1973cited by this paper
• The detection of psychiatric illness by questionnaire : a technique for the identification and assessment of non-psychotic psychiatric illness

  1972cited by this paper
• Manual for the State-Trait Anxiety Inventory

  1970cited by this paper
• Severe Agoraphobia: A Controlled Prospective Trial of Behaviour Therapy

  1966cited by this paper
• The assessment of anxiety states by rating.

  1959cited by this paper

• Anxiety and depression in emerging adults: The STAND program as a model of scalable screening and intervention

  2025cites this paper
• Role of the Psychiatrist in Sports Concussion

  2024cites this paper
• Neural Underpinnings of Fine Motor Skills Under Stress and Anxiety: A Review.

  2024cites this paper
• Mechanical Affective Touch Therapy for Anxiety Disorders: Effects on Resting State Functional Connectivity.

  2022cites this paper
• Augmentation of Psychotherapy with D-Cycloserine in Patients with Anxiety Disorders

  2021cites this paper
• Nature as a mental health intervention: State of the science and programmatic possibilities for the conservation community

  2021cites this paper
• Transfer of exposure therapy effects to a threat context not considered during treatment in patients with panic disorder and agoraphobia: Implications for potential mechanisms of change.

  2021cites this paper
• Pharmaceutical Management of General Anxiety Disorder

  2021cites this paper
• Cognitive-Behavioral Treatments for Anxiety and Stress-Related Disorders.

  2021cites this paper
• Dose Timing of D-Cycloserine to Augment Cognitive Behavioral Therapy for Social Anxiety Disorder

  2020cites this paper
• Guided Internet-Based Cognitive Behavioral Therapy in Japanese Patients With Obsessive-Compulsive Disorder: Protocol for a Randomized Controlled Trial

  2020cites this paper
• Transdiagnostic preventative intervention for subclinical anxiety: Development and initial validation.

  2020cites this paper
• The efficacy of group cognitive-behavioural therapy plus duloxetine for generalised anxiety disorder versus duloxetine alone

  2019cites this paper
• Cognitive Behavioral Therapy for Anxiety Disorders

  2019cites this paper
• A Preliminary Exploration of the Barriers to Delivering (and Receiving) Exposure-Based Cognitive Behavioral Therapy for Anxiety Disorders in Adult Community Mental Health Settings

  2018cites this paper
• Moving to Beat Anxiety: Epidemiology and Therapeutic Issues with Physical Activity for Anxiety

  2018cites this paper
• Applicability Evaluation of Simplified Cognitive Behavioral Therapy

  2018cites this paper
• Anxiety Disorders

  2018cites this paper
• Hatha yoga for acute, chronic and/or treatment-resistant mood and anxiety disorders: A systematic review and meta-analysis

  2018cites this paper
• The Apprehension/Fear and Somatic Preoccupation/Somatisation Dimensions

  2018cites this paper
• Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder

  2018influential citation
• Know Thyself: Well-Being and Subjective Experience

  2018cites this paper
• Dimensional Psychopathology

  2018cites this paper
• Treatment Utilization by Adults with Autism and Co-Occurring Anxiety or Depression.

  2018cites this paper
• Computer-Assisted Cognitive-Behavior Therapy in Medical Care Settings

  2018cites this paper
• Study Protocol for a Randomized Double Blind, Placebo Controlled Trial Exploring the Effectiveness of a Micronutrient Formula in Improving Symptoms of Anxiety and Depression

  2018cites this paper
• Neue pharmakologische Strategien zur Augmentation von Extinktionslernen in der Angsttherapie

  2017cites this paper
• The Melatonergic System in Anxiety Disorders and the Role of Melatonin in Conditional Fear.

  2017cites this paper
• Combined Treatment With CBT and Psychopharmacology

  2017cites this paper
• Self-Reported Lifetime Depression and Current Mental Distress Among Veterans Across Service Eras.

  2017cites this paper
• New pharmacological strategies for augmenting extinction learning in anxiety disorders

  2017cites this paper
• D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data

  2017cites this paper
• Can Cognitive Behavioral Therapy for Anxiety and Depression Be Improved with Pharmacotherapy? A Meta-analysis.

  2017cites this paper
• Morbid Anxiety: Identification and Treatment.

  2017cites this paper
• D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety , Obsessive-Compulsive , and Posttraumatic Stress Disorders

  2017cites this paper
• Anxiety Disorders: Evidence-Based Integrated Biopsychosocial Treatment

  2017cites this paper
• Treatment Choice Among Combat Veterans

  2017cites this paper
• Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.

  2016cites this paper
• The Efficacy of Body-Oriented Yoga in Mental Disorders–A Systematic Review and Meta-Analysis

  2016cites this paper
• A Cognitive-Neuropsychological Account of Treatment Action in Anxiety: Can We Augment Clinical Efficacy?

  2016cites this paper
• Internet-Based Cognitive Behavior Therapy for Social Anxiety Disorder

  2016cites this paper
• Treatment-resistant panic disorder: clinical significance, concept and management.

  2016cites this paper
• Neuroenhancement of Exposure Therapy in Anxiety Disorders

  2015cites this paper
• Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.

  2015cites this paper
• Has evidence-based psychosocial treatment for anxiety disorders permeated usual care in community mental health settings?

  2015cites this paper
• Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.

  2015cites this paper
• Orexins and fear: implications for the treatment of anxiety disorders.

  2015cites this paper
• Parents’ Perceptions of Novel Treatments for Child and Adolescent Specific Phobia and Anxiety Disorders

  2015cites this paper
• Combined Neuropeptide S and D-Cycloserine Augmentation Prevents the Return of Fear in Extinction-Impaired Rodents: Advantage of Dual versus Single Drug Approaches

  2015cites this paper
• Zur Rolle der Exposition bei der Therapie von Angststörungen

  2015cites this paper
• Panic Disorder and Agoraphobia

  2014cites this paper
• Combination treatment of psychological treatment and pharmacotherapy

  2014cites this paper
• Anxiety Disorders in Primary Care

  2014cites this paper
• What is Exposure Therapy and How Does It Differ from Other Treatments ?

  2014cites this paper
• Translational Research in Social Anxiety: Summary of Newest Developments and Future Directions

  2014cites this paper
• Combination Psychological and Pharmacological Treatments for Panic Disorder

  2014cites this paper
• A Comparison between Psychosocial and Pharmacological Treatments

  2014cites this paper
• Bridging the gap: Lessons we have learnt from the merging of psychology and psychiatry for the optimisation of treatments for emotional disorders.

  2014cites this paper
• Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks.

  2014cites this paper
• Treatment of Anxiety Disorders: State of the Art

  2014cites this paper
• From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.

  2014cites this paper
• Update on the efficacy of pharmacotherapy for social anxiety disorder: a meta-analysis

  2014cites this paper
• Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review.

  2014cites this paper
• Cognitive enhancers for the treatment of anxiety disorders

  2014cites this paper
• Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta‐analysis

  2014cites this paper
• The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.

  2014cites this paper
• Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

  2014cites this paper
• D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders

  2013cites this paper
• Can fMRI be used to predict the course of treatment for social anxiety disorder?

  2013cites this paper
• Anxiety Disorders in Women

  2013cites this paper
• Neurobiologically-motivated treatments for post-traumatic stress disorder in an animal model

  2013cites this paper
• Cognitive Change Across Cognitive-Behavioral and Light Therapy Treatments for Seasonal Affective Disorder: What Accounts for Clinical Status the Next Winter?

  2013cites this paper
• Anxiety Disorders in Children and Adolescents

  2012cites this paper
• Cognitive‐Behavioral Therapy for Anxiety Disorders

  2012cites this paper
• A Roadmap for the Research and Practice of Combination Strategies

  2012cites this paper
• The Biology and Efficacy of Combination Strategies for Anxiety Disorders

  2012cites this paper
• [Anxiety disorders].

  2012cites this paper
• Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial.

  2012cites this paper
• Cognitive Enhancers in Exposure Therapy for Anxiety and Related Disorders

  2012cites this paper
• D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.

  2012cites this paper
• Cognitive enhancers for facilitating drug cue extinction: insights from animal models.

  2011cites this paper
• Pharmacological treatment of generalized anxiety disorder

  2011cites this paper
• Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study

  2011cites this paper
• Pharmacotherapy of PTSD

  2011cites this paper
• Anxiety disorders: assessment and management in general practice

  2011cites this paper
• Cognitive enhancers for anxiety disorders.

  2011cites this paper
• Treatment-Refractory Generalized Anxiety Disorder

  2011cites this paper
• Treatment of panic.

  2010cites this paper
• Chapter 21 – Comparison between Psychosocial and Pharmacological Treatments

  2010cites this paper
• Novel approaches to treatment of generalized anxiety disorder

  2010cites this paper
• Double Standards in Psychotherapy Research

  2010cites this paper
• Combining cognitive behavioural therapy and pharmacotherapy in the treatment of anxiety disorders: True gains or false hopes?

  2009cites this paper